文献速递肝病消化道肿瘤与早癌

代谢重编程及其对肝癌的临床意义

Metabolic reprogramming and its clinical implication for liver cancer.
PubMed 文献 · Hepatology · 2023-01-03

本文综述肝细胞癌(HCC)与胆管癌(CCA)的代谢重编程,指出两种肿瘤代谢高度异质,但糖酵解增强和乳酸生成增加(Warburg效应)常见;并讨论非酒精性脂肪性肝病(NAFLD)代谢及全基因组代谢模型等系统生物学方法在识别治疗靶点与个体化治疗中的价值。

要点

  • HCC与CCA代谢高度异质,但糖酵解增强和乳酸生成增加(Warburg效应)常见。
  • β-catenin激活的HCC依赖脂肪酸分解代谢,而脂肪肝来源HCC避免使用脂肪酸。
  • 全基因组代谢模型等系统生物学方法有助于识别肝癌治疗靶点与个体化治疗。

核心结论

  • 肝癌代谢重编程具有高度异质性,既有HCC与CCA共有的代谢改变,也有其亚群特有的代谢特征。

研究设计与样本

  • 综述,描述HCC与CCA的代谢改变、NAFLD代谢及肝癌代谢的临床意义。

主要发现

  • HCC与CCA在病因、突变图谱、转录组和组织学表现上具有高度瘤间异质性,其代谢亦高度异质。
  • 糖酵解途径改变和乳酸生成增加(Warburg效应)在HCC或CCA肿瘤中常被检测到。
  • β-catenin激活的HCC肿瘤依赖脂肪酸分解代谢,而脂肪肝来源的HCC肿瘤避免使用脂肪酸。
  • NAFLD因西方世界肥胖流行,可能在未来数年成为肝癌的主要病因。

临床怎么用

  • 作者提出全基因组代谢模型等计算与系统生物学方法是有价值的工具,可用于识别肝癌治疗靶点并开发个体化治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer cells often encounter hypoxic and hypo-nutrient conditions, which force them to make adaptive changes to meet their high demands for energy and various biomaterials for biomass synthesis. As a result, enhanced catabolism (breakdown of macromolecules for energy production) and anabolism (macromolecule synthesis from bio-precursors) are induced in cancer. This phenomenon is called "metabolic reprogramming," a cancer hallmark contributing to cancer development, metastasis, and drug resistance. HCC and cholangiocarcinoma (CCA) are 2 different liver cancers with high intertumoral heterogeneity in terms of etiologies, mutational landscapes, transcriptomes, and histological representations. In agreement, metabolism in HCC or CCA is remarkably heterogeneous, although changes in the glycolytic pathways and an increase in the generation of lactate (the Warburg effect) have been frequently detected in those tumors. For example, HCC tumors with activated β-catenin are addicted to fatty acid catabolism, whereas HCC tumors derived from fatty liver avoid using fatty acids. In this review, we describe common metabolic alterations in HCC and CCA as well as metabolic features unique for their subsets. We discuss metabolism of NAFLD as well, because NAFLD will likely become a leading etiology of liver cancer in the coming years due to the obesity epidemic in the Western world. Furthermore, we outline the clinical implication of liver cancer metabolism and highlight the computation and systems biology approaches, such as genome-wide metabolic models, as a valuable tool allowing us to identify therapeutic targets and develop personalized treatments for liver cancer patients.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yang F, Hilakivi-Clarke L, Shaha A, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology. 2023. PMID: 36626639. doi:10.1097/HEP.0000000000000005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。